In this study, we investigated whether cisplatin treatment triggers TRAIL‐mediated cytotoxicity in TRAIL‐resistant IMR‐32 neuroblastoma cells which exhibit amplification of MYCN oncogene and lack caspase‐8 expression. This evidence concerns the gene TNFSF10 and neuroblastoma.